Literature DB >> 18047896

Perspectives on the state-of-the-science in rehabilitation medicine and its implications for Medicare postacute care policies.

Barbara Gage1, Margaret Stineman, Anne Deutsch, Trudy Mallinson, Allen Heinemann, Shulamit Bernard, Roberta Constantine.   

Abstract

Better measurement of the case-mix complexity of patients receiving rehabilitation services is critical to understanding variations in the outcomes achieved by patients treated in different postacute care (PAC) settings. The Medicare program recognized this issue and is undertaking a major initiative to develop a new patient-assessment instrument that would standardize case-mix measurement in inpatient rehabilitation facilities, long-term care hospitals, skilled nursing facilities, and home health agencies. The new instrument, called the Continuity Assessment Record and Evaluation Tool, builds on the scientific advances in measurement to develop standard measures of medical acuity, functional status, cognitive impairment, and social support related to resource need, outcomes, and continuity of care for use in all PAC settings.

Entities:  

Mesh:

Year:  2007        PMID: 18047896      PMCID: PMC4310210          DOI: 10.1016/j.apmr.2007.09.025

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  10 in total

1.  Outcomes and reimbursement of inpatient rehabilitation facilities and subacute rehabilitation programs for Medicare beneficiaries with hip fracture.

Authors:  Anne Deutsch; Carl V Granger; Roger C Fiedler; Gerben DeJong; Robert L Kane; Kenneth J Ottenbacher; Allen W Heinemann; John P Naughton; Maurizio Trevisan
Journal:  Med Care       Date:  2005-09       Impact factor: 2.983

2.  Poststroke rehabilitation: outcomes and reimbursement of inpatient rehabilitation facilities and subacute rehabilitation programs.

Authors:  Anne Deutsch; Carl V Granger; Allen W Heinemann; Roger C Fiedler; Gerben DeJong; Robert L Kane; Kenneth J Ottenbacher; John P Naughton; Maurizio Trevisan
Journal:  Stroke       Date:  2006-04-20       Impact factor: 7.914

3.  Changes in the use of postacute care during the initial Medicare payment reforms.

Authors:  Wen-Chieh Lin; Robert L Kane; David R Mehr; Richard W Madsen; Gregory F Petroski
Journal:  Health Serv Res       Date:  2006-08       Impact factor: 3.402

4.  Outcomes and costs after hip fracture and stroke. A comparison of rehabilitation settings.

Authors:  A M Kramer; J F Steiner; R E Schlenker; T B Eilertsen; C A Hrincevich; D A Tropea; L A Ahmad; D G Eckhoff
Journal:  JAMA       Date:  1997-02-05       Impact factor: 56.272

5.  A case-mix classification system for medical rehabilitation.

Authors:  M G Stineman; J J Escarce; J E Goin; B B Hamilton; C V Granger; S V Williams
Journal:  Med Care       Date:  1994-04       Impact factor: 2.983

6.  Translating measures across the continuum of care: using Rasch analysis to create a crosswalk between the Functional Independence Measure and the Minimum Data Set.

Authors:  Craig A Velozo; Katherine L Byers; Ying-Chih Wang; Bryttnee Roberts Joseph
Journal:  J Rehabil Res Dev       Date:  2007

7.  Do rehabilitative nursing homes improve the outcomes of care?

Authors:  R L Kane; Q Chen; L A Blewett; J Sangl
Journal:  J Am Geriatr Soc       Date:  1996-05       Impact factor: 5.562

8.  State-level variation in Medicare spending.

Authors:  B Gage; M Moon; S Chi
Journal:  Health Care Financ Rev       Date:  1999

9.  Impact of the BBA on post-acute utilization.

Authors:  B Gage
Journal:  Health Care Financ Rev       Date:  1999

10.  Overview: Medicare post-acute care since the Balanced Budget Act of 1997.

Authors:  Philip G Cotterill; Barbara J Gage
Journal:  Health Care Financ Rev       Date:  2002
  10 in total
  1 in total

1.  Hospital readmission in persons with stroke following postacute inpatient rehabilitation.

Authors:  K J Ottenbacher; J E Graham; A J Ottenbacher; J Lee; S Al Snih; A Karmarkar; T Reistetter; G V Ostir
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-03-02       Impact factor: 6.053

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.